177
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Visceral Adipose Tissue Volume and the Occurrence of Colorectal Adenoma in Follow-up Colonoscopy for Screening and Surveillance

, , , , , , , , & show all
Pages 739-745 | Received 02 Aug 2016, Accepted 27 Feb 2017, Published online: 01 Jun 2017

References

  • Siegel R, Desantis C, and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 64, 104–117, 2014.
  • Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, et al.: Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366, 687–696, 2012.
  • Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, et al.: Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143, 844–857, 2012.
  • Yun KE, Chang Y, Jung HS, Kim CW, Kwon MJ, et al.: Impact of body mass index on the risk of colorectal adenoma in a metabolically healthy population. Cancer Res 73, 4020–4027, 2013.
  • Omata F, Deshpande GA, Ohde S, Mine T, and Fukui T: The association between obesity and colorectal adenoma: systematic review and meta-analysis. Scand J Gastroenterol 48, 136–146, 2013.
  • Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, et al.: Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 107, 1175–1185; quiz 1186, 2012.
  • Ben Q, An W, Jiang Y, Zhan X, Du Y, et al.: Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142, 762–772, 2012.
  • Stein B, Anderson JC, Rajapakse R, Alpern ZA, Messina CR, et al.: Body mass index as a predictor of colorectal neoplasia in ethnically diverse screening population. Dig Dis Sci 55, 2945–2952, 2010.
  • Kaaks R, Lukanova A, and Kurzer MS: Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11, 1531–1543, 2002.
  • Giovannucci E: Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131, 3109S–3120S, 2001.
  • Donohoe CL, Doyle SL, and Reynolds JV: Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 3, 12, 2011.
  • Kang HW, Kim D, Kim HJ, Kim CH, Kim YS, et al.: Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol 105, 178–187, 2010.
  • Keum N, Lee DH, Kim R, Greenwood DC, and Giovannucci EL: Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies. Ann Oncol 26, 1101–1109, 2015.
  • Yamaji T, Iwasaki M, Sasazuki S, Kurahashi N, Mutoh M, et al.: Visceral fat volume and the prevalence of colorectal adenoma. Am J Epidemiol 170, 1502–1511, 2009.
  • Nagata N, Sakamoto K, Arai T, Niikura R, Shimbo T, et al.: Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma. Int J Cancer 135, 2273–2281, 2014.
  • Sass DA, Schoen RE, Weissfeld JL, Weissfeld L, Thaete FL, et al.: Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am J Gastroenterol 99, 687–693, 2004.
  • Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, et al.: Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91, 1147–1154, 1999.
  • Nam SY, Kim BC, Han KS, Ryu KH, Park BJ, et al.: Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes. Clin Gastroenterol Hepatol 8, 443–450 e441–442, 2010.
  • Willett WC, Dietz WH, and Colditz GA: Guidelines for healthy weight. N Engl J Med 341, 427–434, 1999.
  • Han TS, van Leer EM, Seidell JC, and Lean ME: Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311, 1401–1405, 1995.
  • Hong SN, Yang DH, Kim YH, Hong SP, Shin SJ, et al.: Korean guidelines for post-polypectomy colonoscopic surveillance. Korean J Gastroenterol 59, 99–117, 2012.
  • Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P, et al.: Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol 20, 5177–5190, 2014.
  • Oh TH, Byeon JS, Myung SJ, Yang SK, Choi KS, et al.: Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol 23, 411–417, 2008.
  • Shinchi K, Kono S, Honjo S, Todoroki I, Sakurai Y, et al.: Obesity and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 85, 479–484, 1994.
  • Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, et al.: Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98, 920–931, 2006.
  • Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, et al.: Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122, 327–334, 1995.
  • Hu FB: Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34, 1249–1257, 2011.
  • Ning Y, Wang L, and Giovannucci EL: A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11, 19–30, 2010.
  • Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, et al.: Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 31, 500–506, 2007.
  • Fung T, Hu FB, Fuchs C, Giovannucci E, Hunter DJ, et al.: Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med 163, 309–314, 2003.
  • Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, et al.: Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101, 256–266, 2009.
  • Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, et al.: Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) 2, 310–321, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.